Benzodiazepine Discontinuation Difficulties in Panic Disorder: Conceptual Model and Outcome for Cognitive-Behavior Therapy

Author(s): M. W. Otto, J. J. Hong, S. A. Safren.

Journal Name: Current Pharmaceutical Design

Volume 8 , Issue 1 , 2002

Abstract:

There is consistent support for the efficacy of cognitive-behavior therapy (CBT) to aid the successful discontinuation of benzodiazepine (BZ) medication in patients with panic disorder, and help these individuals maintain treatment gains while off medication. In this article, we provide a conceptual model for BZ discontinuation difficulties in patients with panic disorder. Outcome studies are reviewed, and are placed in the context of other evidence for the efficacy of CBT in patients with this disorder.

Keywords: Cognitive-Behavior

Rights & PermissionsPrintExport

Article Details

VOLUME: 8
ISSUE: 1
Year: 2002
Page: [75 - 80]
Pages: 6
DOI: 10.2174/1381612023396726

Article Metrics

PDF: 11
HTML: 0
EPUB: 0
PRC: 0